]>
IRCT20260105068560N1 IRCT 2026-09-27 The University of Lorestan Efficacy of Schema Therapy and Metacognitive Therapy Based on the Health Anxiety Model on Quality of Life and Health Anxiety–Related Symptoms in Patients with Health Anxiety The Effectiveness of Schema Therapy and Metacognitive Therapy Based on the Health Anxiety Model on Quality of Life, Reduction of Anxiety Sensitivity, and Intolerance of Uncertainty in Individuals with Health Anxiety 2026-10-02 anticipated 3 Recruiting https://irct.ir/trial/92687 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. N/A Health anxiety. Intervention group: A single-subject design was employed; therefore, neither an intervention group nor a control group was used. Yes - There is a plan to make this available What will be shared: The data include de-identified individual participant data and scores for anxiety sensitivity, intolerance of uncertainty, and quality of life collected during the baseline, intervention, and follow-up phases. Identifying information will not be shared. When: The data will be available six months after publication of the primary study results or after final approval of the dissertation, whichever is later. To whom: Researchers, faculty members, and graduate students affiliated with reputable academic or research institutions may request access. Conditions: The data may be used only for scientific and research purposes, such as reanalysis and verification of reproducibility. Re-identification of participants, commercial use, and transfer to third parties are prohibited. Data use is subject to request approval and confidentiality requirements. Where to obtain: Applicants should submit a request describing the research purpose, requested data, proposed analysis, and institutional affiliation to the principal investigator. Principal investigator: [Full name] Email: [Email address] Institutional affiliation: [University/Institution] How to obtain: Requests will be reviewed for completeness, scientific relevance, and ethical compliance. Approved applicants must agree to maintain confidentiality. An initial decision will generally be provided within 30 business days, after which the data will be transferred through a secure channel. Comments:
public Samaneh Ghadampour
No. 38, Saviz Alley, Oqaf St., Tehran
Tehran Iran (Islamic Republic of) 3391434847 +98 21 3601 1744 samaneh.ghadampour@gmail.com Lorestan University scientific Samaneh Ghadampour
No. 38, Saviz Alley, Oqaf St., Tehran
Tehran Iran (Islamic Republic of) 3391434847 +98 21 3601 1744 samaneh.ghadampour@gmail.com Lorestan University Iran (Islamic Republic of) High scores on the Health Anxiety Questionnaire; age between 18 and 55 years; and absence of physical health conditions or comorbid psychiatric disorders 18 years 55 years Female The presence of physical illnesses or comorbid psychiatric disorders; age below 18 or above 55 years; and low scores on the Health Anxiety Questionnaire. N/A Intervention group: A single-subject design was employed; therefore, neither an intervention group nor a control group was used Anxiety Sensitivity, Intolerance of Uncertainty. Timepoint: Measurement of the dependent variables was conducted over 12 weekly sessions, followed by two follow-up sessions scheduled one month apart. Method of measurement: Salkovskis et al.’s Health Anxiety Inventory (HAI)؛ Taylor and Cox Anxiety Sensitivity Questionnaire؛ Freeston et al.’s Intolerance of Uncertainty Questionnaire. Quality of Life. Timepoint: The intervention consisted of 12 weekly sessions, followed by two follow-up sessions at one-month intervals. Method of measurement: World Health Organization Quality of Life Questionnaire (WHOQOL). Lorestan University Approved 2025-12-01 Ethics Committee of Lorestan University of Medical Sciences No. 38, Saviz Lane, Oghaf Street, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)